Form 4: iRhythm Technologies CFO Sells 3,000 Shares Under Pre-Arranged Trading Plan
Insider Transaction Report
iRhythm Technologies, Inc.'s Chief Financial Officer, Daniel G. Wilson, sold 3,000 shares of common stock for $150 per share as part of a pre-established Rule 10b5-1 trading plan.
Summary
- Daniel G. Wilson, the Chief Financial Officer of iRhythm Technologies, Inc. (IRTC), reported the sale of 3,000 shares of common stock.
- The transaction occurred on June 23, 2025, with a sale price of $150 per share.
- Following this transaction, Mr. Wilson directly beneficially owns 40,307 shares of iRhythm Technologies common stock.
- The sale was executed pursuant to a Rule 10b5-1 trading plan, which was established by Mr. Wilson on November 14, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While insider selling can sometimes be perceived negatively, the explicit mention of a Rule 10b5-1 trading plan established well in advance mitigates any negative signal, indicating a pre-planned liquidity event rather than a reaction to new information.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, established well in advance on November 14, 2024, indicating a pre-planned and automated transaction rather than a discretionary sale based on new, non-public information.
Negatives
- The Chief Financial Officer, a key insider, reduced his direct beneficial ownership in the company by selling 3,000 shares.
Future Outlook
N/A
Industry Context
This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends. It reflects an individual executive's pre-planned share disposition.
Stakeholder Impact
- Shareholders: The sale by a key executive slightly reduces insider ownership, which some investors may view as a minor negative, though mitigated by the 10b5-1 plan.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 11/14/2024 | Date Rule 10b5-1 trading plan was established by Daniel G. Wilson. |
| 06/23/2025 | Date of common stock transaction (sale of 3,000 shares). |
| 06/24/2025 | Date the Form 4 filing was signed. |
Keywords
iRhythm Technologies, IRTC, Form 4, Insider Trading, Stock Sale, Daniel G. Wilson, CFO, Rule 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.